Prescription Drug Pricing Research
Original analysis from Script Unlock's network of 62,000+ verified US pharmacies. Real price data. Transparent methodology. Updated continuously.
Why Independent Pharmacies Charge Less for Generic Drugs
Analysis of price data from 62,000+ pharmacies showing independent pharmacies price generics 40-60% lower than chains — and why.
The True Cost of DIR Fees on Independent Pharmacy Survival
How PBM Direct and Indirect Remuneration fees have driven 3,000+ independent pharmacy closures and what's being done about it.
Prescription Prices in 2026: What's Going Up, What's Going Down
GLP-1 biologics up 8%. Generics down 12%. Compounded alternatives creating new price floors. The full picture.
When Cash Pay Beats Insurance: A Data-Driven Analysis
For 34% of generic prescriptions, the cash price via Script Unlock is lower than the insurance copay. Here's the data.
The GLP-1 Compounding Market: Size, Quality, and Safety
How compounded semaglutide became a $4.2B market, quality standards from PCAB-accredited pharmacies, and price comparison vs brand.
GoodRx Data Practices: What the FTC Found
Full analysis of the FTC's 2023 complaint against GoodRx: what data was shared, with whom, and what it means for patients.